Geode Capital Management, LLC Neuro Sense Therapeutics Ltd. Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
A detailed history of Geode Capital Management, LLC transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Geode Capital Management, LLC holds 15,870 shares of NRSN stock, worth $15,552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,870
Previous 15,870
-0.0%
Holding current value
$15,552
Previous $29,000
34.48%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NRSN
# of Institutions
11Shares Held
278KCall Options Held
0Put Options Held
0-
Squarepoint Ops LLC New York, NY95.4KShares$93,4670.0% of portfolio
-
Morgan Stanley New York, NY66.4KShares$65,0720.0% of portfolio
-
Meitav Dash Investments LTD40KShares$39,2000.0% of portfolio
-
Two Sigma Investments, LP New York, NY21.1KShares$20,6640.0% of portfolio
-
Commonwealth Equity Services, LLC21.1KShares$20,6580.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $11.4M